PERSONALIZED PROGNOSIS MODELING IN MEDICAL TREATMENT PLANNING

Patent №

US 7,844,560

Granted

2010-11-30

Filed 2007

Owner

SIEMENS MEDICAL SOLUTIONS USA, INC.

Lab

AI components

1

planning

Assignment

Recorded

Dataset

AIPD

2023_r1 edition

Application

11735720

Automated treatment planning is provided with individual specific consideration. One or more prognosis models indicate survivability as a function of patient specific information for a given dose. By determining survivability for a plurality of doses, the biological model represented by survivability as a function of dose is determined from the specific patient. Similarly, the chances of complications or side effects are determined. The chance of survivability and chance of complication are used as or instead of the tumor control probability and normal tissue complications probability, respectively. The desired tumor dosage and tolerance dosage are selected as a function of the patient specific dose distributions. The selected dosages are input to an inverse treatment planning system for establishing radiation treatment parameters.

PlanningA61N 5/103G16H 20/10G16H 20/40G16H 50/50A61N 2005/1041G16H 50/30

AI classification

Planning0.82
Knowledge representation0.27
AI hardware0.01
Machine learning0.00
Evolutionary computation0.00
Vision0.00
Natural language0.00
Speech0.00

Ownership

SIEMENS MEDICAL SOLUTIONS USA, INC.

assignment · 196910164

Assignors

KRISHNAN, SRIRAM, RAO, R. BHARAT, AMIES, CHRISTOPHER JUDE

On an employer assignment, the assignors are typically the inventors.

© 2026 NYSGPT2525 LLC